Howard Marks BIOMARIN PHARMACEUTICAL INC Transaction History

Oaktree Capital Management LP

2,936,000

0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	N/A	2,936,000 New	2,936,000 $0
Q4 2023 Feb 13, 2024	BUY	N/A	7,867,000 New	7,867,000 $0
Q2 2023 Aug 11, 2023	SELL	N/A	-2,113,000 Reduced 32.21%	4,448,000 $0
Q1 2023 Aug 25, 2023	BUY	N/A	2,113,000 Added 47.5%	6,561,000 $0
Q1 2023 May 15, 2023	BUY	N/A	4,098,000 Added 166.38%	6,561,000 $0
Q4 2022 Feb 14, 2023	BUY	N/A	763,000 Added 44.88%	2,463,000 $2.62 Million
Q2 2022 Aug 15, 2022	SELL	N/A	-1,800,000 Reduced 51.43%	1,700,000 $1.69 Million
Q1 2022 May 16, 2022	SELL	N/A	-603,000 Reduced 14.7%	3,500,000 $3.51 Million
Q4 2021 Feb 14, 2022	SELL	N/A	-95,000 Reduced 2.26%	4,103,000 $0
Q3 2021 Nov 15, 2021	SELL	N/A	-4,302,000 Reduced 50.61%	4,198,000 $0
Q2 2021 Aug 16, 2021	BUY	N/A	8,030,000 Added 1708.51%	8,500,000 $8.83 Million
Q1 2020 May 15, 2020	SELL	N/A	-3,030,000 Reduced 86.57%	470,000 $0
Q4 2019 Feb 14, 2020	BUY	N/A	3,500,000 New	3,500,000 $0
Q2 2019 Aug 14, 2019	SELL	N/A	-2,100,000 Closed	0 $0
Q1 2019 May 14, 2019	SELL	N/A	-5,300,000 Reduced 71.62%	2,100,000 $2.15 Million
Q4 2018 Feb 15, 2019	SELL	N/A	-11,465,000 Reduced 60.77%	7,400,000 $7.38 Million
Q3 2018 Nov 14, 2018	SELL	N/A	-11,635,000 Reduced 38.15%	18,865,000 $20.2 Million
Q2 2018 Aug 14, 2018	BUY	N/A	25,547,000 Added 515.79%	30,500,000 $30.9 Million
Q3 2017 Nov 14, 2017	BUY	N/A	4,953,000	4,953,000 $5.04 Million

Get notified when there are updates to the investment portfolio of Oaktree Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Oaktree Capital Management LP and Howard Marks with notifications on news.